Page last updated: 2024-11-05

triazolam and Amaurosis

triazolam has been researched along with Amaurosis in 2 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van Reeth, O2
Zhang, Y1
Reddy, A1
Zee, P1
Turek, FW2

Other Studies

2 other studies available for triazolam and Amaurosis

ArticleYear
Aging alters the entraining effects of an activity-inducing stimulus on the circadian clock.
    Brain research, 1993, Apr-02, Volume: 607, Issue:1-2

    Topics: Aging; Animals; Arousal; Blindness; Circadian Rhythm; Cricetinae; Eye Enucleation; Mesocricetus; Mot

1993
Administering triazolam on a circadian basis entrains the activity rhythm of hamsters.
    The American journal of physiology, 1989, Volume: 256, Issue:3 Pt 2

    Topics: Animals; Blindness; Circadian Rhythm; Cricetinae; Male; Mesocricetus; Motor Activity; Triazolam

1989